Skip to main content
SpringerLink
Log in

Anti-Hsp90 therapy in autoimmune and inflammatory diseases: a review of preclinical studies

  • Mini Review
  • Published:
Cell Stress and Chaperones Aims and scope

Abstract

Heat shock protein 90 (Hsp90), a 90-kDa molecular chaperone, is responsible for biological activities of key signaling molecules (clients) such as protein kinases, ubiquitin ligases, steroid receptors, cell cycle regulators, and transcription factors regulating various cellular processes, including growth, survival, differentiation, and apoptosis. Because Hsp90 is also involved in stabilization of oncogenic ‘client’ proteins, its specific chaperone activity blockers are currently being tested as anticancer agents in advanced clinical trials. Recent in vitro and in vivo studies have shown that Hsp90 is also involved in activation of innate and adaptive cells of the immune system. For these reasons, pharmacological inhibition of Hsp90 has been evaluated in murine models of autoimmune and inflammatory diseases. This mini-review summarizes current knowledge of the effects of Hsp90 inhibitors on autoimmune and inflammatory diseases’ features and is based solely on preclinical studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  • Ambade A, Catalano D, Lim A, Kopoyan A, Shaffer SA, Mandrekar P (2014) Inhibition of heat shock protein 90 alleviates steatosis and macrophage activation in murine alcoholic liver injury. J Hepatol 61:903–911

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bae J, Munshi A, Li C, Samur M, Prabhala R, Mitsiades C, Anderson KC, Munshi NC (2013) Heat shock protein 90 is critical for regulation of phenotype and functional activity of human T lymphocytes and NK cells. J Immunol 190:1360–1371

    Article  CAS  PubMed  Google Scholar 

  • Barbatis C, Tsopanomichalou M (2009) Heat shock proteins in inflammatory bowel disease. Ann Gastroenterol 22:244–247

    Google Scholar 

  • Borges TJ, Wieten L, van Herwijnen MJ, Broere F, van der Zee R, Bonorino C, van Eden W (2012) The anti-inflammatory mechanisms of Hsp70. Front Immunol 3:95

    Article  PubMed  PubMed Central  Google Scholar 

  • Chatterjee A, Dimitropoulou C, Drakopanayiotakis F, Antonova G, Snead C, Cannon J, Venema RC, Catravas JD (2007) Heat shock protein 90 inhibitors prolong survival, attenuate inflammation, and reduce lung injury in murine sepsis. Am J Respir Crit Care Med 176:667–675

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Collins CB, Aherne CM, Yeckes A, Pound K, Eltzschig HK, Jedlicka P, de Zoeten EF (2013) Inhibition of N-terminal ATPase on HSP90 attenuates colitis through enhanced Treg function. Mucosal Immunol 6:960–971

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Constantinescu CS, Farooqi N, O’Brien K, Gran B (2011) Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). Br J Pharmacol 164:1079–1106

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Davidson A, Diamond B (2001) Autoimmune diseases. N Engl J Med 345:340–350

    Article  CAS  PubMed  Google Scholar 

  • Dello Russo C, Polak PE, Mercado PR, Spagnolo A, Sharp A, Murphy P, Kamal A, Burrows FJ, Fritz LC, Feinstein DL (2006) The heat-shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin suppresses glial inflammatory responses and ameliorates experimental autoimmune encephalomyelitis. J Neurochem 99:1351–1362

    Article  PubMed  Google Scholar 

  • Felts SJ, Owen BA, Nguyen P, Trepel J, Donner DB, Toft DO (2000) The hsp90-related protein TRAP1 is a mitochondrial protein with distinct functional properties. J Biol Chem 275:3305–3312

    Article  CAS  PubMed  Google Scholar 

  • Firestein GS (2003) Evolving concepts of rheumatoid arthritis. Nature 423:356–361

    Article  CAS  PubMed  Google Scholar 

  • Garcia-Carbonero R, Carnero A, Paz-Ares L (2013) Inhibition of HSP90 molecular chaperones: moving into the clinic. Lancet Oncol 14:e358–e369

    Article  CAS  PubMed  Google Scholar 

  • Han JM, Kwon NH, Lee JY, Jeong SJ, Jung HJ, Kim HR, Li Z, Kim S (2010) Identification of gp96 as a novel target for treatment of autoimmune disease in mice. PLoS One 5, e9792

    Article  PubMed  PubMed Central  Google Scholar 

  • Kampinga HH, Hageman J, Vos MJ, Kubota H, Tanguay RM, Bruford EA, Cheetham ME, Chen B, Hightower LE (2009) Guidelines for the nomenclature of the human heat shock proteins. Cell Stress Chaperones 14:105–111

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kasperkiewicz M, Schmidt E (2009) Current treatment of autoimmune blistering diseases. Curr Drug Discov Technol 6:270–280

    Article  CAS  PubMed  Google Scholar 

  • Kasperkiewicz M, Muller R, Manz R, Magens M, Hammers CM et al (2011) Heat-shock protein 90 inhibition in autoimmunity to type VII collagen: evidence that nonmalignant plasma cells are not therapeutic targets. Blood 117:6135–6142

    Article  CAS  PubMed  Google Scholar 

  • Langer T, Rosmus S, Fasold H (2003) Intracellular localization of the 90 kDA heat shock protein (HSP90alpha) determined by expression of a EGFP-HSP90alpha-fusion protein in unstressed and heat stressed 3T3 cells. Cell Biol Int 27:47–52

    Article  CAS  PubMed  Google Scholar 

  • Li J, Buchner J (2013) Structure, function and regulation of the hsp90 machinery. Biomed J 36:106–117

    Article  PubMed  Google Scholar 

  • Li W, Tsen F, Sahu D, Bhatia A, Chen M, Multhoff G, Woodley DT (2013) Extracellular Hsp90 (eHsp90) as the actual target in clinical trials: intentionally or unintentionally. Int Rev Cell Mol Biol 303:203–235

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lilja A, Weeden CE, McArthur K, Nguyen T, Donald A, Wong ZX, Dousha L, Bozinovski S, Vlahos R, Burns CJ, Asselin-Labat ML, Anderson GP (2015) HSP90 inhibition suppresses lipopolysaccharide-induced lung inflammation in vivo. PLoS One 10, e0114975

    Article  PubMed  PubMed Central  Google Scholar 

  • Ludwig RJ, Zillikens D (2011) Pathogenesis of epidermolysis bullosa acquisita. Dermatol Clin 29:493–501

    Article  CAS  PubMed  Google Scholar 

  • Mazzarella RA, Green M (1987) ERp99, an abundant, conserved glycoprotein of the endoplasmic reticulum, is homologous to the 90-kDa heat shock protein (hsp90) and the 94-kDa glucose regulated protein (GRP94). J Biol Chem 262:8875–8883

    CAS  PubMed  Google Scholar 

  • McConnell JR, Buckton LK, McAlpine SR (2015) Regulating the master regulator: controlling heat shock factor 1 as a chemotherapy approach. Bioorg Med Chem Lett 25:3409–3414

    Article  CAS  PubMed  Google Scholar 

  • Mollapour M, Neckers L (2012) Post-translational modifications of Hsp90 and their contributions to chaperone regulation. Biochim Biophys Acta 1823:648–655

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Monrad S, Kaplan MJ (2007) Dendritic cells and the immunopathogenesis of systemic lupus erythematosus. Immunol Res 37:135–145

    Article  CAS  PubMed  Google Scholar 

  • Murphy P, Sharp A, Shin J, Gavrilyuk V, Dello Russo C, Weinberg G, Sharp FR, Lu A, Heneka MT, Feinstein DL (2002) Suppressive effects of ansamycins on inducible nitric oxide synthase expression and the development of experimental autoimmune encephalomyelitis. J Neurosci Res 67:461–470

  • Perry D, Sang A, Yin Y, Zheng YY, Morel L (2011) Murine models of systemic lupus erythematosus. J Biomed Biotechnol 2011:271694

    Article  PubMed  PubMed Central  Google Scholar 

  • Pockley AG (2003) Heat shock proteins as regulators of the immune response. Lancet 362:469–476

    Article  CAS  PubMed  Google Scholar 

  • Poulaki V, Iliaki E, Mitsiades N, Mitsiades CS, Paulus YN, Bula DV, Gragoudas ES, Miller JW (2007) Inhibition of Hsp90 attenuates inflammation in endotoxin-induced uveitis. FASEB J 21:2113–2123

    Article  CAS  PubMed  Google Scholar 

  • Rice JW, Veal JM, Fadden RP, Barabasz AF, Partridge JM, Barta TE, Dubois LG, Huang KH, Mabbett SR, Silinski MA, Steed PM, Hall SE (2008) Small molecule inhibitors of Hsp90 potently affect inflammatory disease pathways and exhibit activity in models of rheumatoid arthritis. Arthritis Rheum 58:3765–3775

    Article  CAS  PubMed  Google Scholar 

  • Rosman Z, Shoenfeld Y, Zandman-Goddard G (2013) Biologic therapy for autoimmune diseases: an update. BMC Med 11:88

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Shimp SK 3rd, Chafin CB, Regna NL, Hammond SE, Read MA, Caudell DL, Rylander M, Reilly CM (2012) Heat shock protein 90 inhibition by 17-DMAG lessens disease in the MRL/lpr mouse model of systemic lupus erythematosus. Cell Mol Immunol 9:255–266

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Shukla HD, Pitha PM (2012) Role of hsp90 in systemic lupus erythematosus and its clinical relevance. Autoimmune Dis 2012:728605

    PubMed  PubMed Central  Google Scholar 

  • Sorger PK, Pelham HR (1987) The glucose-regulated protein grp94 is related to heat shock protein hsp90. J Mol Biol 194:341–344

    Article  CAS  PubMed  Google Scholar 

  • Srivastava P (2002) Roles of heat-shock proteins in innate and adaptive immunity. Nat Rev Immunol 2:185–194

    Article  CAS  PubMed  Google Scholar 

  • Stocki P, Dickinson AM (2012) The immunosuppressive activity of heat shock protein 70. Autoimmune Dis 2012:617213

    PubMed  PubMed Central  Google Scholar 

  • Trepel J, Mollapour M, Giaccone G, Neckers L (2010) Targeting the dynamic HSP90 complex in cancer. Nat Rev Cancer 10:537–549

    Article  CAS  PubMed  Google Scholar 

  • Tukaj S, Kleszczyński K, Vafia K, Groth S, Meyersburg D, Trzonkowski P, Ludwig RJ, Zillikens D, Schmidt E, Fischer TW, Kasperkiewicz M (2013) Aberrant expression and secretion of heat shock protein 90 in patients with bullous pemphigoid. PLoS One 8, e70496

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tukaj S, Zillikens D, Kasperkiewicz M (2014a) Inhibitory effects of heat shock protein 90 blockade on proinflammatory human Th1 and Th17 cell subpopulations. J Inflamm (Lond) 11:10

    Article  Google Scholar 

  • Tukaj S, Tiburzy B, Manz R, de Castro MA, Orosz A, Ludwig RJ, Zillikens D, Kasperkiewicz M (2014b) Immunomodulatory effects of heat shock protein 90 inhibition on humoral immune responses. Exp Dermatol 23:585–590

    Article  CAS  PubMed  Google Scholar 

  • Tukaj S, Grüner D, Zillikens D, Kasperkiewicz M (2014c) Hsp90 blockade modulates bullous pemphigoid IgG-induced IL-8 production by keratinocytes. Cell Stress Chaperones 19:887–894

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tukaj S, Hellberg L, Ueck C, Hänsel M, Samavedam U, Zillikens D, Ludwig R, Laskay T, Kasperkiewicz M (2015) Heat shock protein 90 is required for ex vivo neutrophil-driven autoantibody-induced tissue damage in experimental epidermolysis bullosa acquisita. Exp Dermatol 24:567–571

    Article  CAS  PubMed  Google Scholar 

  • van Eden W, van der Zee R, Prakken B (2005) Heat-shock proteins induce T-cell regulation of chronic inflammation. Nat Rev Immunol 5:318–330

    Article  PubMed  Google Scholar 

  • Wieten L, Broere F, van der Zee R, Koerkamp EK, Wagenaar J, van Eden W (2007) Cell stress induced HSP are targets of regulatory T cells: a role for HSP inducing compounds as anti-inflammatory immuno-modulators? FEBS Lett 581:3716–3722

    Article  CAS  PubMed  Google Scholar 

  • Whitesell L, Lindquist SL (2005) HSP90 and the chaperoning of cancer. Nat Rev Cancer 5:761–772

  • Yun TJ, Harning EK, Giza K, Rabah D, Li P, Arndt JW, Luchetti D, Biamonte MA, Shi J, Lundgren K, Manning A, Kehry MR (2011) EC144, a synthetic inhibitor of heat shock protein 90, blocks innate and adaptive immune responses in models of inflammation and autoimmunity. J Immunol 186:563–575

    Article  CAS  PubMed  Google Scholar 

  • Zhang H, Zhang L, Yu F, Liu Y, Liang Q, Deng G, Chen G, Liu M, Xiao X (2012) HSF1 is a transcriptional activator of IL-10 gene expression in RAW264.7 macrophages. Inflammation 35:1558–1566

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Molecular Biology, Faculty of Biology, University of Gdańsk, Wita Stwosza 59, 80-308, Gdańsk, Poland

    Stefan Tukaj & Grzegorz Węgrzyn

Authors
  1. Stefan Tukaj
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Grzegorz Węgrzyn
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stefan Tukaj.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tukaj, S., Węgrzyn, G. Anti-Hsp90 therapy in autoimmune and inflammatory diseases: a review of preclinical studies. Cell Stress and Chaperones 21, 213–218 (2016). https://doi.org/10.1007/s12192-016-0670-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12192-016-0670-z

Keywords

Search

Navigation